-
Product Insights
NewAlpha Galactosidase A – Drugs In Development, 2024
The Alpha Galactosidase A pipeline drugs market research report outlays comprehensive information on the Alpha Galactosidase A targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Fabry Disease. It also reviews key players involved in Alpha Galactosidase A targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...
-
Product Insights
NewGalactocerebrosidase – Drugs In Development, 2024
The Galactocerebrosidase pipeline drugs market research report outlays comprehensive information on the Galactocerebrosidase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System which include indications of Globoid Cell Leukodystrophy (Krabbe Disease). It also reviews key players involved in Galactocerebrosidase targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is an...
-
Product Insights
NewPoly – Drugs In Development, 2024
The Poly pipeline drugs market research report outlays comprehensive information on the Poly targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Unspecified Cancer, and Solid Tumor. It also reviews key players involved in Poly targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is an “on-demand” report...
-
Product Insights
NewCD276 Antigen – Drugs In Development, 2024
The CD276 Antigen pipeline drugs market research report outlays comprehensive information on the CD276 Antigen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Solid Tumor, and Unspecified Cancer. It also reviews key players involved in CD276 Antigen targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Product Insights
NewPoliovirus Receptor – Drugs In Development, 2024
The Poliovirus Receptor pipeline drugs market research report outlays comprehensive information on the Poliovirus Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Unspecified Cancer, and Solid Tumor. It also reviews key players involved in Poliovirus Receptor targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Product Insights
NewAngiotensinogen – Drugs In Development, 2024
The Angiotensinogen pipeline drugs market research report outlays comprehensive information on the Angiotensinogen targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, and Metabolic Disorders which include indications of Hypertension, Resistant Hypertension, and Hypertriglyceridemia. It also reviews key players involved in Angiotensinogen targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Product Insights
NewMyotonin Protein Kinase – Drugs In Development, 2024
The Myotonin Protein Kinase pipeline drugs market research report outlays comprehensive information on the Myotonin Protein Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Musculoskeletal Disorders which include indications of Myotonic Dystrophy. It also reviews key players involved in Myotonin Protein Kinase targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...
-
Product Insights
NewClaudin 18 – Drugs In Development, 2024
The Claudin 18 pipeline drugs market research report outlays comprehensive information on the Claudin 18 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, and Undisclosed which include indications of Gastric Cancer, Solid Tumor, and Unspecified. It also reviews key players involved in Claudin 18 targeted therapeutics development with respective active and dormant or discontinued projects. Note:...
-
Product Insights
NewNS5B – Drugs In Development, 2024
The NS5B pipeline drugs market research report outlays comprehensive information on the NS5B targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Infectious Disease which include indications of Hepatitis C, and Coronavirus Disease 2019 (COVID-19). It also reviews key players involved in NS5B targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This is...
-
Product Insights
NewPhenylalanine 4 Hydroxylase – Drugs In Development, 2024
The Phenylalanine 4 Hydroxylase pipeline drugs market research report outlays comprehensive information on the Phenylalanine 4 Hydroxylase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders which include indications of Phenylketonuria (PKU). It also reviews key players involved in Phenylalanine 4 Hydroxylase targeted therapeutics development with respective active and dormant or discontinued projects. Note: * This...